Abstract:Background/Aims: Survivin, a member of the inhibitor of apoptosis protein family, is an attractive target for cancer therapy. We investigated the effects of YM155, a small molecule inhibitor of survivin expression, on the radiosensitivity of human non-small cell lung cancer (NSCLC) cell lines and elucidated a relationship between the cellular localization of survivin and DNA double-strand break repair. Methods: The cellular distribution of survivin was determined by Western blotting of subcellular fractions and by immunofluorescent staining in A549 NSCLC cells. Radiation-induced DNA damage was evaluated based on histone H2AX phosphorylation and foci formation. The relationship between the cellular localization of survivin and DNA double-strand break repair was analyzed by Western blotting and co-immunoprecipitations. Results: YM155 down-regulated survivin expression in NSCLC cells in a concentration- and time-dependent manner. An in vitro clonogenic survival assay revealed that YM155 increased the sensitivity of NSCLC cells to radiation. After irradiation, we observed a rapid accumulation of survivin in the nucleus. An immunofluorescent analysis of histone γ-H2AX demonstrated that the inhibition of survivin expression by YM155 resulted in impaired DNA double-strand break repair. Co-immunoprecipitation assays using nuclear extracts revealed an interaction between survivin, Ku70, γ-H2AX, and DNA-PKcs. Furthermore, S2056 autophosphorylation of DNA-PKcs was reduced in survivin-depleted cells. Conclusions: These results suggested that YM155 sensitized NSCLC cells to radiation, at least in part by inhibiting DNA repair and enhancing apoptosis via the down-regulation of survivin expression. YM155 pretreatment inhibited DNA-PKcs autophosphorylation at S2056. Nuclear survivin was involved in DNA double-strand break repair via interactions with members of the DNA double-strand break repair machinery.

Promotion of Ubiquitination-Dependent Survivin Destruction Contributes to Xanthohumol-Mediated Tumor Suppression and Overcomes Radioresistance in Human Oral Squamous Cell Carcinoma.

Co-Inhibition Of Glut-1 Expression And The Pi3k/Akt Signaling Pathway To Enhance The Radiosensitivity Of Laryngeal Carcinoma Xenografts In Vivo

Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer

The Survivin Suppressant YM155 Reverses Doxorubicin Resistance in Osteosarcoma.

Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo

Xanthohumol Inhibits Proliferation of Laryngeal Squamous Cell Carcinoma.

Author Correction: Butein Promotes Ubiquitination-Mediated Survivin Degradation Inhibits Tumor Growth and Overcomes Chemoresistance

Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-κB pathway

Exploration of pro-apoptotic effect of Thymoquinone on oral squamous cell carcinoma cells through PI3K/Akt signaling pathway

Slug Inhibition Increases Radiosensitivity of Oral Squamous Cell Carcinoma Cells by Upregulating PUMA.

The Mechanism of Radiosensitization by YM155, a Novel Small Molecule Inhibitor of Survivin Expression, is Associated with DNA Damage Repair

Effect of Verbascoside on Apoptosis and Metastasis in Human Oral Squamous Cell Carcinoma.

Targeting Aurora B kinase with Tanshinone IIA Suppresses Tumor Growth and Overcomes Radioresistance

Enhancing tumor radiosensitivity by intracellular delivery of survivin antagonists.

Dual Induction of Apoptotic and Autophagic Cell Death by Targeting Survivin in Head Neck Squamous Cell Carcinoma

Induced Epigenetic Modifications of the Promoter Chromatin Silence Survivin and Inhibit Tumor Growth.

Combined Class I Histone Deacetylase and Mtorc1/c2 Inhibition Suppresses the Initiation and Recurrence of Oral Squamous Cell Carcinomas by Repressing SOX2.

Physcion 8-O-β-glucopyranoside Induces Mitochondria-Dependent Apoptosis of Human Oral Squamous Cell Carcinoma Cells Via Suppressing Survivin Expression

Inhibition of Breast Cancer Cell Survival by Xanthohumol Via Modulation of the Notch Signaling Pathway in Vivo and in Vitro

Enhanced tumor radiosensitivity by a survivin dominant-negative mutant